Brought to you by 
Teva acquires drug delivery company MicroDose Therapeutx for $40mm up front
26 Aug 2020
Executive Summary
Teva Pharmaceutical Industries Ltd. has paid $40mm up front for MicroDose Therapeutx Inc., a private maker of inhalation and oral drug delivery systems. MicroDose is also eligible for up to $125mm in development and regulatory earn-outs, plus undisclosed sales milestones and tiered royalties tied to commercialization of the company’s lead candidate MDT637 and an early-stage asthma/COPD program.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Pulmonary
- Transdermal
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Teva acquires drug delivery company MicroDose Therapeutx for $40mm up front
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice